CLINICAL_TRIALS
trial_result
· 2015-07-23
Clinical Trial Update: A Study of MabThera (Rituximab) in Patients With Advanced Non-Hodgkin's Lymphoma [Phase 3]
Summary
This is a Phase 3 clinical trial update evaluating MabThera (rituximab) in patients with advanced non-Hodgkin lymphoma. Results from the study were posted on 20…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Non-Hodgkin's Lymphoma | Phase 3 | Status: COMPLETED | Results posted: 2015-07-23